GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » Debt-to-Revenue

Bioporto AS (OCSE:BIOPOR) Debt-to-Revenue : 0.35 (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bioporto AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr3.34 Mil. Bioporto AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr7.85 Mil. Bioporto AS's annualized Revenue for the quarter that ended in Dec. 2024 was kr31.59 Mil. Bioporto AS's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.35.


Bioporto AS Debt-to-Revenue Historical Data

The historical data trend for Bioporto AS's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS Debt-to-Revenue Chart

Bioporto AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.54 0.37 0.23 0.31

Bioporto AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.17 0.16 0.12 0.35

Competitive Comparison of Bioporto AS's Debt-to-Revenue

For the Diagnostics & Research subindustry, Bioporto AS's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioporto AS's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bioporto AS's Debt-to-Revenue falls into.


;
;

Bioporto AS Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bioporto AS's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.344 + 7.846) / 36.243
=0.31

Bioporto AS's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.344 + 7.846) / 31.588
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Bioporto AS Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioporto AS's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioporto AS Business Description

Traded in Other Exchanges
Address
Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines